IP Library Assignment 036380/0942
Patent Assignment
Reel/Frame 036380/0942

Change of Name

Recorded: 2015-08-18 Pages: 3
Assignor
APTALIS PHARMATECH, INC.
Executed: 2015-04-29
Assignee
ADARE PHARMACEUTICALS, INC.
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Property (1)
Pulsatile Release Histamine H2 Antagonist Dosage Form
Patent: 6,663,888 →
Application: 10/057,759 →
Publication: US 2003/0113374
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Aug 30, 2012
From: EURAND, INC.
To: APTALIS PHARMATECH, INC.
Reel/Frame 028884/0903 →
Release of Lien on Patents Oct 24, 2013
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMATECH, INC.
Reel/Frame 031494/0925 →
Patent Security Agreement Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
U.S. Patent Security Agreement Dec 8, 2015
From: ADARE PHARMACEUTICALS, INC.
To: BANK OF MONTREAL
Reel/Frame 037246/0313 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276 Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Security Interest Sep 22, 2020
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: CRESCENT AGENCY SERVICES LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 053849/0967 →
Security Interest Nov 8, 2022
From: ADARE PHARMACEUTICALS, INC.; ADARE PHARMACEUTICALS USA, INC.
To: TEAL MIDCO HOLDINGS, L.P.
Reel/Frame 061698/0541 →